Amatoxin 중독 환자에서 Silymarin, Penicillin, N-acetylcysteine의 효과 비교: 체계적 고찰
Comparison of Silymarin, Penicillin, N-acetylcysteine in Patient with Amatoxin Poisoning: A Systematic Review
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study was conducted to evaluate the clinical efficacy of pharmacologic treatment of amatoxin poisoning patients. Methods: Literature was accessed through PubMed, EMBASE, Cochrane library, KoreaMed, KISS and KMBASE. Studies relevant to human use of pharmacologic therapy including silymarin, penicillin and N-acetylcysteine (NAC) for amanita poisoning were included. Case reports, letters, editorials and papers with insufficient information were excluded. Comparison of clinical outcomes (especially mortality and liver transplantation rate) in each study was analyzed. Results: The final analysis included 13 retrospective studies. None of these studies showed direct comparisons of individual agents. Among 12 studies comparing silymarin vs penicillin, eight showed clinical superiority of silymarin. Among eight studies comparing silymarin with NAC, six showed clinical superiority of silymarin. Among seven studies of NAC vs penicillin, five showed clinical superiority of NAC. Conclusion: This systematic review suggested that clinical superiority of various pharmacological agents used to treat amatoxin poisoning is debatable. Nevertheless, the available evidence suggests it is reasonable to consider combinations of multiple agents for patients with amanita poisoning. Further studies are required to establish a treatment regimen for amanita poisoning.
Abstract
Purpose: This study was conducted to evaluate the clinical efficacy of pharmacologic treatment of amatoxin poisoning patients. Methods: Literature was accessed through PubMed, EMBASE, Cochrane library, KoreaMed, KISS and KMBASE. Studies relevant to human use of pharmacologic therapy including silymarin, penicillin and N-acetylcysteine (NAC) for amanita poisoning were included. Case reports, letters, editorials and papers with insufficient information were excluded. Comparison of clinical outcomes (especially mortality and liver transplantation rate) in each study was analyzed. Results: The final analysis included 13 retrospective studies. None of these studies showed direct comparisons of individual agents. Among 12 studies comparing silymarin vs penicillin, eight showed clinical superiority of silymarin. Among eight studies comparing silymarin with NAC, six showed clinical superiority of silymarin. Among seven studies of NAC vs penicillin, five showed clinical superiority of NAC. Conclusion: This systematic review suggested that clinical superiority of various pharmacological agents used to treat amatoxin poisoning is debatable. Nevertheless, the available evidence suggests it is reasonable to consider combinations of multiple agents for patients with amanita poisoning. Further studies are required to establish a treatment regimen for amanita poisoning.
참고문헌 (30)
- 손창환, "국내 독버섯 중독의 유형과 치료", 대한의사협회지, 58(9), pp.818~824 (2015), 대한의사협회[DOI]
- Smith MR, "Mycetismus: a review", Gastroenterol Rep, 4, pp.107~112 (2016)[DOI]
- Mengs U, "<TEX>$Legalon^{(R)}$<", TEX> SIL: the antidote of choice in patients with acute hepatotoxicvity from amatoxins poisoning, 2012, pp.13, 1964~1970
- Ye Y, "Management of Amanita phalloides poisoning; A literature review and update", J Crit Care, 46, pp.17~22 (2018)[DOI]
- Garcia J, "Amanita phalloides poisoning: Mechanisms of toxicity and treatment", Food Chem Toxicol, 86, pp.41~55 (2015)[DOI]
- Moher D, "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement", J Clin Epidemiol, 62, pp.1006~1012 (2009)[DOI]
- Berger KJ, "Mycotoxins revisited: part I", J Emerg Med, 28, pp.53~62 (2005)[DOI]
- Polyak SJ, "Silymarin for HCV infection", Antivir Ther, 18, pp.141~147 (2013)[DOI]
- Saller R, "The use of silymarin in the treatment of liver disease", Drugs, 61, pp.2035~2063 (2001)[DOI]
- Post-White J, "Advances in the use of milk thistle", Intergrr Cancer Ther, 6, pp.104~109 (2007)[DOI]
- Rambaldi A, "Milk thistle for alcoholic and", or hepatitis B or C virus liver diseases, 2005, pp.2, ~
- Zuber R, "Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities", Phytother Res, 16, pp.632~638 (2002)[DOI]
- Enjalbert F, "Treatment of amatoxin poisoning: 20-year retrospective analysis", J Toxicol Clin Toxicol, 40, pp.715~757 (2002)[DOI]
- Poucheret P, "Amatoxin poisoning treatment decision-making: Pharmaco-therapeutic clinical strategy assessment using multidimensional multivariate statistic analysis", Toxicon, 55, pp.1338~1345 (2010)[DOI]
- Garcia J, "A breakthrough on Amanita phalloides poisoning: an effective antidotal effect by polymyxin B", Arch Toxicol, 89, pp.2305~2323 (2015)[DOI]
- Rifai K, "Prometheus--a new extracorporeal system for the treatment of liver failure", J Hepatol, 39, pp.984~990 (2003)[DOI]
- Pillukat MH, "Early initiation of MARS(R) dialysis in Amanita phalloides-induced acute liver injury prevents liver transplantation", Ann Hepatol, 15, pp.775~787 (2016)
- Zilker TR, "Grading of severity and therapy of 154 cases of Amanita poisoning", Vet Hum Toxicol, 35, pp.331~336 (1993)
- Zilker TH, "Prognosis and treatment of amatoxin poisoning", Clin Toxicol, 47, pp.467~ (2009)
- Ganzert M., "Amanita poisoning-conparison of silibinin with a combination silibinin and penicillin", Dtsch Med Wochenschr, 133, pp.2261~2267 (2008)[DOI]
- Rengstorff DS, "Recovery from severe hepatitis caused by mushroom poisoning without liver transplantation", Clin Gastroenterol Hepatol, 1, pp.392~396 (2003)[DOI]
- Ahishali E, "Approach to mushroom intoxication and treatment: can we decrease mortality?", Clin Res Hepatol Gastroenterol, 36, pp.139~145 (2012)[DOI]
- Robert DM, "Amanita phalloides poisoning and treatment with silibinin in the Australian capital territory and New South Wales", Med J Austr, 198, pp.43~47 (2013)[DOI]
- Akin A, "The effect of N-acetylcysteine in patients with Amanita phalloides intoxication", J Drug Metab Toxicol, 4, pp.1~3 (2013)
- Krenova M, "Survey of Amanita phalloides poisoning: clinical findings and follow-up evaluation", Hum Exp Toxicol, 26, pp.955~961 (2007)[DOI]
- Fix OK, "Acute liver failure due to mushroom poisoning in the United States: Results from the ALFSG registry", Hepatology, 54, pp.497A~ (2011)
- Karvellas CJ, "Acute liver injury and acute liver failure from mushroom poisoning in North America", Liver Int, 36, pp.1043~1050 (2016)[DOI]
- Trakulsrichai S, "Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning", Int J Gen Med, 10, pp.395~400 (2017)[DOI]